Celyad Oncology SA (CLYYF)

0.35 +0.20 (+133.33%) USD  |  OTCM  |  Mar 06, 16:00
More

Celyad Oncology EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CLYYF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Galapagos NV Upgrade
UCB SA Upgrade
Ion Beam Applications SA Upgrade
Fagron NV Upgrade
AgomAb Therapeutics NV --